Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Diseases”

14,912 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 14,912 results

Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Post-approval studies (Phase 4)Study completedNCT00220922
What this trial is testing

Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 50
Early research (Phase 1)Study completedNCT01682902
What this trial is testing

A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 43
Large-scale testing (Phase 3)Study completedNCT02518945
What this trial is testing

Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University at Buffalo 26
Not applicableStudy completedNCT04538872
What this trial is testing

Learning Strategies for Improving Dual Task Performance in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hasselt University 37
Not applicableUnknownNCT05249595
What this trial is testing

Ultrasound Imaging Based Sensing of Human Ankle Motion Intent and Control Strategies for Ankle Assistance

Who this might be right for
Incomplete Spinal Cord InjuryTransverse Myelitis
North Carolina State University 25
Not applicableNot Yet RecruitingNCT07203157
What this trial is testing

HEAL-SLE: Holistic Energy for Alleviating Lupus Symptoms

Who this might be right for
Systemic Lupus Erythematosus
NYU Langone Health 20
Not applicableStudy completedNCT00336557
What this trial is testing

Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,230
Not applicableLooking for participantsNCT06134219
What this trial is testing

Course for Brain Fatigue After Graves' Disease Controlled Study

Who this might be right for
Graves Disease
Vastra Gotaland Region 96
Large-scale testing (Phase 3)Ended earlyNCT05681481
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid

Who this might be right for
Bullous Pemphigoid
argenx 64
Not applicableStudy completedNCT00001265
What this trial is testing

Study and Treatment of Inflammatory Muscle Diseases

Who this might be right for
DermatomyositisPolymyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 1,325
Not applicableUnknownNCT04300465
What this trial is testing

MySlainte: Testing the Effect of Involving Partners in a CVD Prevention Community Lifestyle Program

Who this might be right for
Rheumatoid ArthritisChronic Kidney DiseasesCardiovascular Risk Factor+1 more
National University of Ireland, Galway, Ireland 64
Testing effectiveness (Phase 2)Study completedNCT00860600
What this trial is testing

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
PhytoHealth Corporation 14
Not applicableEnded earlyNCT03647722
What this trial is testing

Assessing the Induction of Long-term Immune Regulation Following Treatment With Lemtrada® (Alemtuzumab).

Who this might be right for
Multiple Sclerosis
University of Southern California 97
Not applicableStudy completedNCT00001953
What this trial is testing

The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers

Who this might be right for
Sjogren's Syndrome
National Institute of Dental and Craniofacial Research (NIDCR) 32
Testing effectiveness (Phase 2)Looking for participantsNCT05027945
What this trial is testing

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Who this might be right for
ImmunodeficiencyHematopoietic Stem Cell Transplantation
National Cancer Institute (NCI) 54
Not applicableStudy completedNCT02651545
What this trial is testing

Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
State University of New York at Buffalo 60
Not applicableStudy completedNCT04679272
What this trial is testing

Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients

Who this might be right for
Covid19Rheumatoid Arthritis
University Hospital, Montpellier 2,000
Not applicableStudy completedNCT03140995
What this trial is testing

Sleep and Exercise in Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisInflammatory Arthritis
University Hospital of Limerick 20
Post-approval studies (Phase 4)Study completedNCT02573012
What this trial is testing

Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 314
Load More Results